Income Statement AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 10:05:13 13/02/2026 pm IST			5-day change	1st Jan Change
15,118.00 ^GBX	+1.42%		+7.19%	+9.63%

14/02	Sector Update: Health Care Stocks Advance Late Afternoon	MT
14/02	Sector Update: Health Care Stocks Higher Friday Afternoon	MT

364502dc28bbe10e85ccedcea1aa87.HYqD4htbF0-8i2TYIhsDsnmjrDibWrGOZNY-2zxeFeM.fKfciHkjRymI3guiW39k_hHmwHn0H_nKB-VLkkYofLV3svXVSW1uOsymJQ

Published financial data: ASTRAZENECA PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	2.66TCr	3.74TCr	4.44TCr	4.58TCr	5.41TCr
Other Revenues, Total	-	-	-	-	-
Total Revenues	2.66TCr	3.74TCr	4.44TCr	4.58TCr	5.41TCr
Cost of Goods Sold, Total	524.6Cr	979.9Cr	861.9Cr	804Cr	963.8Cr
Gross Profit	2.14TCr	2.76TCr	3.57TCr	3.78TCr	4.44TCr
Selling General & Admin Expenses, Total	1.16TCr	1.45TCr	1.75TCr	1.8TCr	1.95TCr
R&D Expenses	612.3Cr	855.2Cr	952.9Cr	1.03TCr	1.22TCr
Other Operating Expenses	-49Cr	-21Cr	-23Cr	-99Cr	-19Cr
Other Operating Expenses, Total	1.72TCr	2.28TCr	2.68TCr	2.73TCr	3.15TCr
Operating Income	414.8Cr	481.2Cr	896.3Cr	1.04TCr	1.29TCr
Interest Expense, Total	-74Cr	-78Cr	-92Cr	-121.9Cr	-140.3Cr
Interest And Investment Income	7.7Cr	4.3Cr	8.1Cr	30Cr	34Cr
Net Interest Expenses	-66Cr	-73Cr	-84Cr	-92Cr	-105.8Cr
Income (Loss) On Equity Invest.	-2.7Cr	-6.4Cr	-50L	-1.2Cr	-2.8Cr
Currency Exchange Gains (Loss)	-3.4Cr	-2Cr	-1.6Cr	-3.4Cr	-4.2Cr
Other Non Operating Income (Expenses)	-49Cr	-48Cr	-37Cr	-29Cr	-13Cr
EBT, Excl. Unusual Items	293.9Cr	351.7Cr	773.6Cr	917.8Cr	1.17TCr
Restructuring Charges	-25Cr	-128.3Cr	-72Cr	-47Cr	-115.4Cr
Merger & Related Restructuring Charges	-	-244.1Cr	-357.1Cr	-14Cr	-
Gain (Loss) On Sale Of Investments	-	78Cr	-	-	-
Gain (Loss) On Sale Of Assets	105.5Cr	51Cr	22Cr	29Cr	6Cr
Asset Writedown	-25Cr	-206.9Cr	-24Cr	-43Cr	-157.4Cr
Legal Settlements	90L	-4.8Cr	-79Cr	-101.3Cr	-4.8Cr
Other Unusual Items	42Cr	77Cr	-13Cr	-52Cr	-26Cr
EBT, Incl. Unusual Items	391.6Cr	-26Cr	250.1Cr	689.9Cr	869.1Cr
Income Tax Expense	77Cr	-38Cr	-79Cr	94Cr	165Cr
Earnings From Continuing Operations	314.4Cr	12Cr	329.3Cr	596.1Cr	704.1Cr
Net Income to Company	314.4Cr	12Cr	329.3Cr	596.1Cr	704.1Cr
Minority Interest	5.2Cr	-30L	-50L	-60L	-60L
Net Income - (IS)	319.6Cr	11Cr	328.8Cr	595.5Cr	703.5Cr
Net Income to Common Incl Extra Items	319.6Cr	11Cr	328.8Cr	595.5Cr	703.5Cr
Net Income to Common Excl. Extra Items	319.6Cr	11Cr	328.8Cr	595.5Cr	703.5Cr
Per Share Items
Net EPS - Basic	2.44	0.08	2.12	3.84	4.54
Basic EPS - Continuing Operations	2.44	0.08	2.12	3.84	4.54
Basic Weighted Average Shares Outstanding	131.2Cr	141.8Cr	154.8Cr	154.9Cr	155Cr
Net EPS - Diluted	2.44	0.08	2.11	3.81	4.5
Diluted EPS - Continuing Operations	2.44	0.08	2.11	3.81	4.5
Diluted Weighted Average Shares Outstanding	131.3Cr	142.7Cr	156Cr	156.2Cr	156.3Cr
Normalized Basic EPS	1.44	1.55	3.12	3.7	4.7
Normalized Diluted EPS	1.44	1.54	3.1	3.67	4.66
Dividend Per Share	2.8	2.87	2.9	2.9	3.1
Payout Ratio	111.76	3.44T	132.72	75.25	65.8
American Depositary Receipts Ratio (ADR)	0.08	0.08	0.08	0.08	0.08
Supplemental Items
EBITDA	676.4Cr	861.6Cr	1.39TCr	1.5TCr	1.76TCr
EBITA	607.9Cr	789.2Cr	1.3TCr	1.43TCr	1.68TCr
EBIT	414.8Cr	481.2Cr	896.3Cr	1.04TCr	1.29TCr
EBITDAR	676Cr	862.2Cr	-	-	-
Total Revenues (As Reported)	2.66TCr	3.74TCr	4.44TCr	4.58TCr	5.41TCr
Effective Tax Rate - (Ratio)	19.71	143.4	-31.67	13.6	18.99
Total Current Taxes	97Cr	119.5Cr	163.6Cr	244.5Cr	244.5Cr
Total Deferred Taxes	-20Cr	-157.5Cr	-242.8Cr	-150.7Cr	-80Cr
Normalized Net Income	188.89Cr	219.51Cr	483Cr	573.02Cr	728.59Cr
Interest on Long-Term Debt	2.1Cr	2.2Cr	2.4Cr	3.3Cr	6.1Cr
Non-Cash Pension Expense	1.6Cr	3.8Cr	4.2Cr	3.7Cr	6.4Cr
Supplemental Operating Expense Items
Selling and Marketing Expenses	40Cr	45Cr	53Cr	54Cr	56Cr
Research And Development Expense From Footnotes	605.2Cr	981.7Cr	983.8Cr	1.1TCr	1.37TCr
Net Rental Expense, Total	-40L	60L	-	-	-
Imputed Operating Lease Interest Expense	-10.95L	13.28L	-	-	-
Imputed Operating Lease Depreciation	-29.05L	46.72L	-	-	-
Stock-Based Comp., Other (Total)	28Cr	62Cr	62Cr	58Cr	66Cr
Total Stock-Based Compensation	28Cr	62Cr	62Cr	58Cr	66Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	783.2Cr	632.9Cr	616.6Cr	584Cr	548.8Cr
Short Term Investments	4.2Cr	5.3Cr	6.4Cr	-	-
Trading Asset Securities, Total	16Cr	1.6Cr	1.4Cr	2Cr	3.7Cr
Total Cash And Short Term Investments	803.5Cr	639.8Cr	624.4Cr	586Cr	552.5Cr
Accounts Receivable, Total	380.6Cr	603.1Cr	721.2Cr	840.7Cr	830.2Cr
Other Receivables	184.5Cr	276.4Cr	271.1Cr	352.8Cr	479.2Cr
Total Receivables	565.1Cr	879.5Cr	992.3Cr	1.19TCr	1.31TCr
Inventory	402.4Cr	898.3Cr	469.9Cr	542.4Cr	528.8Cr
Prepaid Expenses	173.5Cr	151.2Cr	132.9Cr	161.7Cr	173.7Cr
Restricted Cash	-	-	16Cr	10Cr	13Cr
Other Current Assets, Total	9.9Cr	56Cr	24Cr	12Cr	5.4Cr
Total Current Assets	1.95TCr	2.62TCr	2.26TCr	2.51TCr	2.58TCr
Gross Property Plant And Equipment	1.71TCr	1.85TCr	1.72TCr	1.91TCr	2.05TCr
Accumulated Depreciation	-819.3Cr	-832.4Cr	-774.3Cr	-859.9Cr	-887.5Cr
Net Property Plant And Equipment	891.7Cr	1.02TCr	944.9Cr	1.05TCr	1.16TCr
Long-term Investments	119.2Cr	126.2Cr	114.2Cr	167.7Cr	190Cr
Goodwill	1.18TCr	2TCr	1.98TCr	2TCr	2.1TCr
Other Intangibles, Total	2.09TCr	4.24TCr	3.93TCr	3.81TCr	3.72TCr
Deferred Tax Assets Long-Term	343.8Cr	433Cr	326.3Cr	471.8Cr	534.7Cr
Other Long-Term Assets, Total	85Cr	97Cr	91Cr	103.1Cr	111.2Cr
Total Assets	6.67TCr	11TCr	9.65TCr	10TCr	10TCr
Liabilities
Accounts Payable, Total	235Cr	282.4Cr	255Cr	326.7Cr	364Cr
Accrued Expenses, Total	968.9Cr	1.24TCr	1.34TCr	1.57TCr	1.61TCr
Short-term Borrowings	66Cr	41Cr	531.4Cr	512.9Cr	33Cr
Current Portion of Long-Term Debt	156.6Cr	224.8Cr	96Cr	99Cr	205.7Cr
Current Portion of Leases	19Cr	23Cr	23Cr	27Cr	34Cr
Current Income Taxes Payable	112.7Cr	92Cr	90Cr	158.4Cr	140.6Cr
Unearned Revenue Current, Total	195.8Cr	118.1Cr	27Cr	25Cr	13Cr
Other Current Liabilities	276.4Cr	242.3Cr	264.9Cr	330.8Cr	388Cr
Total Current Liabilities	2.03TCr	2.26TCr	2.63TCr	3.05TCr	2.79TCr
Long-Term Debt	1.98TCr	2.97TCr	2.39TCr	2.24TCr	2.66TCr
Long-Term Leases	49Cr	75Cr	72Cr	86Cr	111.3Cr
Unearned Revenue Non Current	3.8Cr	2.6Cr	1.4Cr	70L	-
Pension & Other Post Retirement Benefits	320.2Cr	245.4Cr	116.8Cr	152Cr	133Cr
Deferred Tax Liability Non Current	291.8Cr	620.6Cr	294.4Cr	284.4Cr	330.5Cr
Other Non Current Liabilities	433.3Cr	432.5Cr	437.3Cr	378Cr	292.9Cr
Total Liabilities	5.11TCr	6.61TCr	5.94TCr	6.2TCr	6.32TCr
Common Stock, Total	33Cr	39Cr	39Cr	39Cr	39Cr
Additional Paid In Capital	797.1Cr	3.51TCr	3.52TCr	3.52TCr	3.52TCr
Retained Earnings	644.2Cr	364.4Cr	312Cr	451.6Cr	722.9Cr
Comprehensive Income and Other	88Cr	11Cr	-162.5Cr	-95Cr	-205.7Cr
Total Common Equity	1.56TCr	3.93TCr	3.7TCr	3.91TCr	4.08TCr
Minority Interest	1.6Cr	1.9Cr	2.1Cr	2.3Cr	8.5Cr
Total Equity	1.56TCr	3.93TCr	3.71TCr	3.92TCr	4.09TCr
Total Liabilities And Equity	6.67TCr	11TCr	9.65TCr	10TCr	10TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	131.27Cr	154.94Cr	154.98Cr	155.02Cr	155.05Cr
ECS Total Common Shares Outstanding	131.27Cr	154.94Cr	154.98Cr	155.02Cr	155.05Cr
Book Value / Share	11.9	25.34	23.9	25.25	26.3
Tangible Book Value	-1.72TCr	-2.31TCr	-2.21TCr	-1.9TCr	-1.74TCr
Tangible Book Value Per Share	-13.08	-14.92	-14.25	-12.25	-11.23
Total Debt	2.27TCr	3.34TCr	3.11TCr	2.96TCr	3.05TCr
Net Debt	1.47TCr	2.7TCr	2.49TCr	2.38TCr	2.49TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	322.8Cr	249.9Cr	111.7Cr	147.6Cr	127.2Cr
Debt Equivalent Oper. Leases	-3.2Cr	4.8Cr	-	-	-
Minority Interest, Total (Incl. Fin. Div)	1.6Cr	1.9Cr	2.1Cr	2.3Cr	8.5Cr
Equity Method Investments, Total	3.9Cr	6.9Cr	7.6Cr	15Cr	27Cr
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	126.2Cr	175.5Cr	142.2Cr	153.1Cr	148.9Cr
Inventories - Work In Process, Total	133.1Cr	521.6Cr	186.4Cr	232.5Cr	228.2Cr
Inventories - Finished Goods, Total	143.1Cr	201.2Cr	141.3Cr	156.8Cr	151.7Cr
Land - (BS)	585.1Cr	637.7Cr	544Cr	646.9Cr	658Cr
Machinery, Total	773.8Cr	790.3Cr	755.6Cr	870.4Cr	885.4Cr
Full Time Employees	76.1T	83.1T	83.5T	89.9T	94.3T
Accumulated Allowance for Doubtful Accounts (Supple)	2.3Cr	2.3Cr	5.9Cr	4.5Cr	3.3Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	319.6Cr	11Cr	328.8Cr	595.5Cr	703.5Cr
Depreciation & Amortization - CF	90Cr	96Cr	109.8Cr	100.5Cr	114.2Cr
Amortization of Goodwill and Intangible Assets - (CF)	193.1Cr	308Cr	408Cr	384.6Cr	383.9Cr
Depreciation & Amortization, Total	283.1Cr	403.9Cr	517.8Cr	485.1Cr	498.1Cr
Amortization of Deferred Charges, Total - (CF)	6.1Cr	6.3Cr	7.6Cr	28Cr	20Cr
(Gain) Loss From Sale Of Asset	-105.5Cr	-51Cr	-22Cr	-29Cr	-6Cr
(Gain) Loss on Sale of Investments - (CF)	-	-78Cr	-	-	-
Asset Writedown & Restructuring Costs	26Cr	242.8Cr	23Cr	46Cr	162.3Cr
(Income) Loss On Equity Investments - (CF)	2.7Cr	6.4Cr	50L	1.2Cr	2.8Cr
Stock-Based Compensation (CF)	-7.2Cr	4.5Cr	2.7Cr	-7.1Cr	4.2Cr
Other Operating Activities, Total	-81Cr	-152Cr	-253.3Cr	-114.6Cr	-109.5Cr
Change In Accounts Receivable	-74Cr	-96Cr	-134.9Cr	-142.5Cr	-162.4Cr
Change In Inventories	-62Cr	157.7Cr	394.1Cr	-67Cr	-13Cr
Change In Accounts Payable	172.1Cr	140.5Cr	116.5Cr	239.4Cr	86Cr
Cash from Operations	479.9Cr	596.3Cr	980.8Cr	1.03TCr	1.19TCr
Capital Expenditure	-96Cr	-109.1Cr	-109.1Cr	-136.1Cr	-192.4Cr
Sale of Property, Plant, and Equipment	11Cr	1.3Cr	28Cr	13Cr	5.5Cr
Cash Acquisitions	-82Cr	-1.01TCr	-103.5Cr	-109.9Cr	-378.2Cr
Sale (Purchase) of Intangible assets	-69Cr	-52Cr	-103.3Cr	-212.6Cr	-253.9Cr
Investment in Marketable and Equity Securities, Total	199.9Cr	60Cr	-14Cr	-8.7Cr	-13Cr
Other Investing Activities, Total	8.7Cr	5.4Cr	6Cr	48Cr	34Cr
Cash from Investing	-28Cr	-1.11TCr	-296Cr	-406.4Cr	-798Cr
Short Term Debt Issued, Total	29Cr	-	7.4Cr	16Cr	-
Long-Term Debt Issued, Total	296.8Cr	1.29TCr	-	381.6Cr	649.2Cr
Total Debt Issued	325.6Cr	1.29TCr	7.4Cr	397.7Cr	649.2Cr
Short Term Debt Repaid, Total	-	-28Cr	-	-	-3.1Cr
Long-Term Debt Repaid, Total	-181.6Cr	-499.9Cr	-151.5Cr	-521Cr	-496.8Cr
Total Debt Repaid	-181.6Cr	-527.5Cr	-151.5Cr	-521Cr	-499.9Cr
Issuance of Common Stock	3Cr	2.9Cr	2.9Cr	3.3Cr	3.8Cr
Repurchase of Common Stock	-	-	-	-	-8.1Cr
Common Dividends Paid	-357.2Cr	-385.6Cr	-436.4Cr	-448.1Cr	-462.9Cr
Common & Preferred Stock Dividends Paid	-357.2Cr	-385.6Cr	-436.4Cr	-448.1Cr	-462.9Cr
Other Financing Activities, Total	-10Cr	-18Cr	-104.7Cr	-89Cr	-82Cr
Cash from Financing	-220.3Cr	364.9Cr	-682.3Cr	-656.7Cr	-399.6Cr
Foreign Exchange Rate Adjustments	1.2Cr	-6.2Cr	-8Cr	-6Cr	-9.3Cr
Net Change in Cash	232.3Cr	-150.8Cr	-5.5Cr	-35Cr	-21Cr
Supplemental Items
Cash Interest Paid	73Cr	72Cr	85Cr	108.1Cr	131.3Cr
Cash Income Tax Paid (Refund)	156.2Cr	174.3Cr	162.3Cr	236.6Cr	275Cr
Levered Free Cash Flow	329.82Cr	-90Cr	1.24TCr	949.94Cr	846.08Cr
Unlevered Free Cash Flow	375.95Cr	-41Cr	1.29TCr	1.01TCr	922.16Cr
Change In Net Working Capital	35Cr	652.3Cr	-358.6Cr	-151.7Cr	12Cr
Net Debt Issued / Repaid	144Cr	765.4Cr	-144.1Cr	-123.3Cr	149.3Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	4.05	3.5	5.55	6.6	7.88
Return on Total Capital	7.07	5.42	7.95	9.52	11.53
Return On Equity %	20.8	0.42	8.63	15.64	17.59
Return on Common Equity	22.23	0.41	8.62	15.63	17.6
Margin Analysis
Gross Profit Margin %	80.29	73.81	80.57	82.45	82.18
SG&A Margin	43.53	38.65	39.39	39.35	35.98
EBITDA Margin %	25.41	23.03	31.33	32.76	32.49
EBITA Margin %	22.84	21.09	29.41	31.17	31.01
EBIT Margin %	15.58	12.86	20.21	22.78	23.91
Income From Continuing Operations Margin %	11.81	0.31	7.42	13.01	13.02
Net Income Margin %	12.01	0.3	7.41	13	13.01
Net Avail. For Common Margin %	12.01	0.3	7.41	13	13.01
Normalized Net Income Margin	7.1	5.87	10.89	12.51	13.47
Levered Free Cash Flow Margin	12.39	-2.4	27.88	20.74	15.65
Unlevered Free Cash Flow Margin	14.12	-1.1	29.17	21.96	17.05
Asset Turnover
Asset Turnover	0.42	0.43	0.44	0.46	0.53
Fixed Assets Turnover	3.09	3.92	4.52	4.59	4.88
Receivables Turnover (Average Receivables)	7.2	7.61	6.7	5.87	6.47
Inventory Turnover (Average Inventory)	1.45	1.51	1.26	1.59	1.8
Short Term Liquidity
Current Ratio	0.96	1.16	0.86	0.82	0.93
Quick Ratio	0.67	0.67	0.61	0.58	0.67
Operating Cash Flow to Current Liabilities	0.24	0.26	0.37	0.34	0.43
Days Sales Outstanding (Average Receivables)	50.82	47.98	54.49	62.22	56.55
Days Outstanding Inventory (Average Inventory)	251.76	242.25	289.7	229.78	203.39
Average Days Payable Outstanding	124.19	63.98	226.24	121.12	133.02
Cash Conversion Cycle (Average Days)	178.38	226.24	117.96	170.89	126.92
Long Term Solvency
Total Debt/Equity	145.24	84.92	84.02	75.7	74.53
Total Debt / Total Capital	59.22	45.92	45.66	43.08	42.7
LT Debt/Equity	129.77	77.56	66.47	59.39	67.86
Long-Term Debt / Total Capital	52.92	41.94	36.12	33.8	38.88
Total Liabilities / Total Assets	76.56	62.71	61.59	61.27	60.71
EBIT / Interest Expense	5.62	6.2	9.77	8.56	9.22
EBITDA / Interest Expense	9.46	11.41	15.42	12.54	12.77
(EBITDA - Capex) / Interest Expense	8.15	10	14.23	11.42	11.39
Total Debt / EBITDA	3.25	3.77	2.2	1.94	1.7
Net Debt / EBITDA	2.1	3.05	1.76	1.56	1.39
Total Debt / (EBITDA - Capex)	3.77	4.3	2.39	2.13	1.91
Net Debt / (EBITDA - Capex)	2.44	3.47	1.91	1.71	1.56
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	9.16	40.58	18.53	3.29	18.03
Gross Profit, 1 Yr. Growth %	9.39	29.23	29.38	5.71	17.64
EBITDA, 1 Yr. Growth %	21.02	27.3	51.91	7.64	23.5
EBITA, 1 Yr. Growth %	23.36	29.82	54.85	9.07	24.26
EBIT, 1 Yr. Growth %	35.2	16.01	67.75	15.78	34.01
Earnings From Cont. Operations, 1 Yr. Growth %	156.23	-96.34	2.76T	81.02	18.12
Net Income, 1 Yr. Growth %	139.4	-96.5	2.84T	81.11	18.14
Normalized Net Income, 1 Yr. Growth %	57.59	16.21	91.14	17.89	39.07
Diluted EPS Before Extra, 1 Yr. Growth %	137.39	-96.76	2.57T	80.57	18.11
Accounts Receivable, 1 Yr. Growth %	6.16	58.46	19.58	16.57	-1.25
Inventory, 1 Yr. Growth %	26.03	123.24	-47.69	15.43	-2.51
Net Property, Plant and Equip., 1 Yr. Growth %	6.98	14.06	-7.1	11.14	10.9
Total Assets, 1 Yr. Growth %	8.72	57.9	-8.43	4.8	2.88
Tangible Book Value, 1 Yr. Growth %	-11.38	34.63	-4.44	-14.02	-8.31
Common Equity, 1 Yr. Growth %	19.01	151.36	-5.68	5.69	4.2
Cash From Operations, 1 Yr. Growth %	61.64	24.26	64.48	5.48	14.65
Capital Expenditures, 1 Yr. Growth %	-1.84	13.53	0	24.75	41.37
Levered Free Cash Flow, 1 Yr. Growth %	-47.03	-127.15	-2.29T	-24.67	-6.08
Unlevered Free Cash Flow, 1 Yr. Growth %	-44.01	-110.93	-16.35T	-22.41	-3.64
Dividend Per Share, 1 Yr. Growth %	0	2.5	1.05	0	6.9
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	9.77	23.87	29.08	10.65	10.42
Gross Profit, 2 Yr. CAGR %	10.24	18.9	29.31	21.92	11.55
EBITDA, 2 Yr. CAGR %	23.12	24.32	40.99	49.67	13.06
EBITA, 2 Yr. CAGR %	26.22	26.55	43.87	54.57	14.05
EBIT, 2 Yr. CAGR %	54.8	25.24	43.21	89.78	21.13
Earnings From Cont. Operations, 2 Yr. CAGR %	23.84	-69.39	2.34	619.96	46.22
Net Income, 2 Yr. CAGR %	21.78	-71.04	1.43	629.18	46.27
Normalized Net Income, 2 Yr. CAGR %	132.93	35.33	54.34	139.59	24.04
Diluted EPS Before Extra, 2 Yr. CAGR %	19.7	-72.26	-6.93	594.53	46.04
Accounts Receivable, 2 Yr. CAGR %	12.73	29.7	37.66	18.07	7.29
Inventory, 2 Yr. CAGR %	18	67.73	8.06	-22.3	6.08
Net Property, Plant and Equip., 2 Yr. CAGR %	9.62	10.47	2.94	1.61	11.02
Total Assets, 2 Yr. CAGR %	4.89	31.02	20.25	-2.03	3.84
Tangible Book Value, 2 Yr. CAGR %	-10	9.23	13.43	-9.35	-11.21
Common Equity, 2 Yr. CAGR %	11.94	72.96	53.97	-0.16	4.94
Cash From Operations, 2 Yr. CAGR %	35.39	41.72	42.96	31.71	9.97
Capital Expenditures, 2 Yr. CAGR %	-4.01	5.57	6.55	11.69	32.8
Levered Free Cash Flow, 2 Yr. CAGR %	-5.56	-62.01	89.55	126.88	-17.68
Unlevered Free Cash Flow, 2 Yr. CAGR %	-4.97	-75.22	82.08	150.11	-15.26
Dividend Per Share, 2 Yr. CAGR %	0	1.24	1.77	0.52	3.39
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.82	19.2	22.07	19.84	13.06
Gross Profit, 3 Yr. CAGR %	5.25	16.24	22.29	20.91	20.47
EBITDA, 3 Yr. CAGR %	4.04	24.53	35.58	29.01	37.89
EBITA, 3 Yr. CAGR %	3.83	27.41	38.33	31.35	41.04
EBIT, 3 Yr. CAGR %	4.01	40.61	42.96	33.66	64.64
Earnings From Cont. Operations, 3 Yr. CAGR %	3.11	-61.72	38.97	23.77	294.14
Net Income, 3 Yr. CAGR %	2.12	-62.68	35.05	23.05	297.51
Normalized Net Income, 3 Yr. CAGR %	6.56	84.75	59.13	41.38	93.98
Diluted EPS Before Extra, 3 Yr. CAGR %	0.92	-64.05	27.16	16.08	284.79
Accounts Receivable, 3 Yr. CAGR %	10.75	26.28	26.24	30.23	11.24
Inventory, 3 Yr. CAGR %	9.86	45.94	13.75	10.46	-16.19
Net Property, Plant and Equip., 3 Yr. CAGR %	5.4	11.08	4.27	5.6	4.62
Total Assets, 3 Yr. CAGR %	1.75	20.21	16.27	14.86	-0.42
Tangible Book Value, 3 Yr. CAGR %	-9.35	2.93	4.47	3.42	-9.01
Common Equity, 3 Yr. CAGR %	1.45	46.58	41.3	35.82	1.27
Cash From Operations, 3 Yr. CAGR %	10.28	31.57	48.93	29.18	25.76
Capital Expenditures, 3 Yr. CAGR %	-10.18	1.51	3.68	12.3	20.82
Levered Free Cash Flow, 3 Yr. CAGR %	-7.7	-37.65	25.78	40.28	66.13
Unlevered Free Cash Flow, 3 Yr. CAGR %	-6.57	-53.76	24.52	37.12	78.98
Dividend Per Share, 3 Yr. CAGR %	0	0.83	1.18	1.18	2.6
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.5	10.22	14.57	15.71	17.27
Gross Profit, 5 Yr. CAGR %	1.11	7.76	14.28	16.52	17.86
EBITDA, 5 Yr. CAGR %	0.53	7.2	18.26	27.46	25.8
EBITA, 5 Yr. CAGR %	0.39	7.4	19.15	30.2	27.75
EBIT, 5 Yr. CAGR %	0.38	4.26	19.45	43.23	33.33
Earnings From Cont. Operations, 5 Yr. CAGR %	2.16	-49.22	2.8	23.8	41.83
Net Income, 5 Yr. CAGR %	2.5	-49.76	1.84	22.54	39.43
Normalized Net Income, 5 Yr. CAGR %	-0.52	4.88	25.34	75.1	43.47
Diluted EPS Before Extra, 5 Yr. CAGR %	1.78	-50.87	-2.3	17.52	34.4
Accounts Receivable, 5 Yr. CAGR %	-3.86	18.48	20.81	22.93	18.29
Inventory, 5 Yr. CAGR %	13.43	30.94	9.14	13.42	10.62
Net Property, Plant and Equip., 5 Yr. CAGR %	6.81	8.23	4.41	7.19	6.92
Total Assets, 5 Yr. CAGR %	2.13	11	8.78	10.76	11.13
Tangible Book Value, 5 Yr. CAGR %	1.48	-1.07	-0.85	-2.17	-2.11
Common Equity, 5 Yr. CAGR %	-3.31	21.46	19.88	25.71	25.45
Cash From Operations, 5 Yr. CAGR %	7.62	7.54	22.35	31.63	31.92
Capital Expenditures, 5 Yr. CAGR %	-6.26	-5.48	-3.83	5.47	14.47
Levered Free Cash Flow, 5 Yr. CAGR %	-2.37	-27.5	24.13	20.77	6.37
Unlevered Free Cash Flow, 5 Yr. CAGR %	-1.06	-38.97	22.92	19.3	6.6
Dividend Per Share, 5 Yr. CAGR %	0	0.5	0.7	0.7	2.06